Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. - Wikidata - wikimedia - TriplyDB

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.

http://www.wikidata.org/entity/Q35587803

about

Pathogenesis of the metabolic syndrome: insights from monogenic disorders ICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATs Enhanced rat beta-cell proliferation in 60% pancreatectomized islets by increased glucose metabolic flux through pyruvate carboxylase pathway The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein.Activated FoxM1 attenuates streptozotocin-mediated β-cell death.Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta cell in rats.Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors.Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression.The use of animal models in diabetes research.The effect of prednisone on pancreatic islet autografts in dogs Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice.Insulin therapy for pre-hyperglycemic beta-cell endoplasmic reticulum crowding.Glucotoxicity and beta-cell failure in type 2 diabetes mellitus.In vivo misfolding of proinsulin below the threshold of frank diabetes.Dapagliflozin lowers plasma glucose concentration and improves β-cell function Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance Regulation of pancreatic beta-cell mass.Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β.TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferation Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins PDX1 in ducts is not required for postnatal formation of β-cells but is necessary for their subsequent maturation.The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.SGLT2 inhibition: a novel prospective strategy in treatment of diabetes mellitus.Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15.TGF-β signalling prevents pancreatic beta cell death after proliferation.Beta-cell rest: a strategy for the prevention of autoimmune diabetes.Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes.Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.Mary, Mary, quite contrary, how do your beta-cells fail?beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression.Effect of dietary carbohydrate, fat, and protein on postprandial glycemia and energy intake in cats.Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs.Muscarinic M1 and M3 receptor binding alterations in pancreas during pancreatic regeneration of young rats.

P2860

Q27024024-5A62E5C3-DA3A-4F9E-8FF4-2867ACB357BC Q28115798-6A7182E2-3A1C-47EF-AAE6-24BB7084D5BF Q28577833-84FE53E2-3B6E-4D76-AD3D-99DDFF234CA1 Q33705046-64BF5E09-12E8-4ADE-8260-B6A5C59E3984 Q34114554-7C3D7F27-F93B-4231-8308-E4CA3317B14B Q34131699-99C6D0C8-FBE0-4D9C-85FA-D4E4924373C3 Q34139310-8FBFF0F8-F7FF-470C-BC0D-E8F809C2525A Q34189030-C85B465C-9C34-43D8-A0A9-4688323F6B30 Q34197036-CCC716E1-4FF9-401B-84AD-CF22B8FF4BBB Q34219847-32DF52BB-331F-4445-9AAC-AC5BCD801E49 Q34228824-22A92013-077D-44C0-8C03-BB70351A5624 Q34255921-4A1BB02A-CECA-4092-A0D7-AFE3A82B40FE Q34356951-B850782D-1C98-48F1-8C8D-93EE01C48466 Q34556799-373A183F-7CB0-436A-877E-5029DBE1532E Q34585855-D5F90060-0E33-481D-AF35-67675DE0C9BD Q35065639-976D51BF-E25A-4C61-9383-8C3FB13D4418 Q35123549-730C5ED2-250A-431F-89F9-689141E06669 Q35578244-543F0E40-F4B5-4067-AC91-B313600146C5 Q35604634-8D733F09-9192-4F16-BEEC-ECF29E5DA349 Q35651511-A8950C00-A8DB-4064-BDF1-C2E72DC5E034 Q35696511-467E5994-0079-4851-B404-5D2D9D1085DC Q36267776-6F420BF5-5718-4694-9E5E-0BEDA9227C59 Q36466996-3D36CDFD-C43A-40DA-A9C8-BF416CB0350E Q36720507-547545F9-CB91-4C16-AB0C-8A755592E961 Q37091579-15198A99-8327-4135-987D-E536A85B5AC5 Q37193305-A3E60467-B064-46F8-A184-9C424D99DE6C Q37424895-FE2C9843-1772-4F8E-9D72-83718459AE86 Q38084363-2A8B8918-45B8-43FB-8294-16D12D9EC598 Q39805384-8AC958FB-56FC-436E-A987-B693C3D0D90F Q40846007-4ABCDBD1-B8FE-442E-8AC2-F65BF22DC922 Q41076082-3873FEFE-4608-4934-96E1-A6B268A5DC5D Q41740281-19B02F07-7F16-491D-AE5C-DA85C489D597 Q41756772-B86FA18C-859C-4C91-8E60-CF889A893EFB Q41810412-DD3E4254-8DE2-4E45-BF7E-C4656D57C735 Q42131322-6B1343BA-95B2-411E-A0EA-0DA648FFC3D7 Q42490543-21B09C13-C444-4E64-9DCC-04AC3A17333D Q43565243-F27BDF21-1A04-452B-9319-BBBD90C88A12 Q44883261-1B947C42-6BC3-43E8-BBE5-521E3F7411C3 Q45103366-570984AF-B2A0-4955-8C6D-97C2B8FA6F7A Q46908746-FC509FCC-7F11-4038-B64A-C3381686AE86

P2860

Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy.

http://www.wikidata.org/entity/Q35587803

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@ast

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@en

type

label

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@ast

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@en

prefLabel

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@ast

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@en

P1433

Q35587803-BEDA32F1-983D-48D5-A77D-6529114B47F5

P1476

Q35587803-A7A73DB7-FBEC-43D0-BAEC-4050FD83D18A

P2093

Q35587803-57CBFF26-2EBA-4C32-B660-3206A68F760D

Q35587803-B39C90C7-56F9-4DE5-8AA9-ADD0F1521355

P2860

Q35587803-12044A3E-2374-4355-BDF4-BB4563781ADA

Q35587803-1DD2804E-3280-480F-B184-96B714503D6C

Q35587803-36C777F7-435C-4730-9084-5006E72C2FF1

Q35587803-3DF35D57-BD91-4CF0-8AE3-4655F3B9C612

Q35587803-3E5CB2FD-DE25-4FED-A35F-649C05C6C773

Q35587803-433F16CD-9D03-43EA-BF50-5355841720EA

Q35587803-5DC630C9-2549-42E7-AE0D-ED7946445D14

Q35587803-5E931A01-800D-47B9-9E92-917292FBD1DC

Q35587803-665C8DA7-E27D-4AAD-A808-AE5A08078AA6

Q35587803-6BC1A6A6-104F-4DBE-90C3-25185D6FEB5A

P304

Q35587803-F7347401-2422-4845-96C0-440EF3E40A04

P31

Q35587803-6D0CB2EB-0373-43BB-98D7-77CC1043E3C2

P356

Q35587803-998F9079-1269-4C84-BB0C-6306E3072E19

P407

Q35587803-81E4BF39-D949-4E59-89D6-A54971FEADD9

P433

Q35587803-1AD5E540-EEBF-4AF9-A08A-15159A5CA21A

P478

Q35587803-5E160DE9-75F0-43F6-B2E4-7B683FCA42F5

P50

Q35587803-D62D5D1E-64BB-4BB1-B2D4-74A17B390704

P577

Q35587803-B348436B-2E8E-4573-836F-F2185E6C6304

P698

Q35587803-5BA8D409-7B9F-4CE9-A790-DC56351053EE

P921

Q35587803-C00FFC9B-B16D-425C-86AF-5BB7F5852E8E

Q35587803-C1D54562-E118-400D-A6E8-78F33AD00E20

P932

Q35587803-8D93693D-0F17-4F3D-83C6-69154C9765B1

P356

P1433

Journal of Clinical Investigation

P1476

Minimal chronic hyperglycemia ...... an incomplete pancreatectomy.

@en

P2093

G C Weir

http://www.w3.org/2001/XMLSchema#string

J L Leahy

http://www.w3.org/2001/XMLSchema#string

P2860

Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions.

Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis

Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes.

Effects of high sucrose or starch-bran diets on glucose and lipid metabolism of normal and diabetic rats.

Insulin and glucose responses in rats fed sucrose or starch.

Effect of high sucrose diet on insulin secretion and insulin action: a study in the normal rat.

Synergistic improvement of glucose tolerance by sucrose feeding and exercise training.

Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats.

P304

1407-1414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI113470

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Susan Bonner-Weir

P577

1988-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3284912

http://www.w3.org/2001/XMLSchema#string

P921

P932

442571

http://www.w3.org/2001/XMLSchema#string